0 Commentarios
0 Acciones
273 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Please log in to like, share and comment!
-
How does the IL-17A inhibitor secukinumab (Cosentyx) change the rules of inflammation management?In the field of immune-mediated inflammatory disease (IMID) treatment, the advent of biologic therapies has broken the limitations of traditional approaches and brought renewed hope for recovery to countless patients. As the world’s first fully human monoclonal antibody targeting interleukin-17A (IL-17A) to receive regulatory approval, secukinumab (Cosentyx) injection has demonstrated...0 Commentarios 0 Acciones 169 Views 0 Vista previa